Biosergen publishes interim report for fourth quarter 2023
Thursday, February 29, 2024: Biosergen AB (“Biosergen” or the “Company”) hereby publishes the interim report for the fourth quarter 2023. The interim report is available as an attached document and on the company website (www.biosergen.net)Summary of the Interim Report for Q4 2023 2023 2022 2023 2022TSEK Oct-Dec Oct-Dec Jan-Dec Jan-Dec Other income 1.315 1.964 9.378 5.183Profit/loss before depreciation (EBITDA) -6.662 -12.491 -27.266